Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation

Leukemia and Lymphoma

Volumn 43, Issue 3, 2002, Pages 503-510

  Mullen, Craig A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Allogeneic bone marrow transplantation; Graft versus tumor effect; GVHD; Tumor vaccines

Indexed keywords

CANCER ANTIBODY; EPITOPE; MINOR HISTOCOMPATIBILITY ANTIGEN; TUMOR ANTIGEN; TUMOR VACCINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CONTROLLED STUDY; DISEASE EXACERBATION; DONOR; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; LEUKEMIA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME;

ANIMALS; BONE MARROW TRANSPLANTATION; CANCER VACCINES; GRAFT VS HOST DISEASE; GRAFT VS TUMOR EFFECT; MICE; MODELS, ANIMAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036125152     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290011976     Document Type: Review

References (35)

1. "Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms"
2. "Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia"
3. "Graft-versus-leukemia reactions after bone marrow transplantation"
4. "Current trends in BMT"
5. "Report from the international bone marrow transplant registry"
6. "Human minor histocompatibility antigens"
7. "Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T-lymphocyte-defined non-MHC antigens"
8. "In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T-cell activities"
9. "Frequency of bone marrow T-cells responding to HLA-identical non-leukemic and leukemic stimulator cells"
10. "Distinct T-cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: A model for separating GVHD from GVL reaction"
11. "Variable capacity of L3T4+ T-cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice"
12. "Minor histocompatibility antigens"
13. "Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice: Prevention by removing mature T-cells from marrow"
14. "Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus"
15. "Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T-cell response to a single dominant MiHA causes graft-versus-host disease"
16. "Positional cloning and molecular characterization of an immunodominant cytotoxic determinant of the mouse H3 minor histocompatibility complex"
17. "Minors held by majors: The H13 minor histocompatibility locus defined as a peptide/MHC class I complex"
18. "Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine"
19. "Shaping the repertoire of cytotoxic T-lymphocyte responses: Explanation for the immunodominance effect whereby cytotoxic T-lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens"
20. "Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease"
21. "Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T-lymphocytes"
22. "Cytotoxic T-cells recognize fragments of the influenza nucleoprotein"
23. "Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumors necrosis and induces systemic immune responses"
24. "Immune surveillance against a solid tumor fails because of immunological ignorance"
25. "Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease"
26. "Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation"
27. "Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation"
28. "Tumor cell vaccine elicits potent or immunity after allogeneic T-cell-depleted bone marrow transplantation"
29. "Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma"
30. "B-cell malignancies as a model for cancer vaccines: From prototype protein to next generation genetic chemokine fusions"
31. "Donor-recipient polymorphism of the proteinase 3 gene: A potential target for T-cell alloresponses to myeloid leukemia"
32. "Cytotoxic T-lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units"
33. "Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases peri-BMT mortality"